RMC No. 56-2022: VAT-Exempt Medicines List Updated for Hypertension and COVID-19 Treatment Under CREATE Act
RMC No. 56-2022 updates the VAT-exempt medicines list for hypertension and COVID-19 treatment under the CREATE Act, requiring item-level VAT review. Pharmacies, hospitals, distributors, importers, clinics, and businesses selling or purchasing medicines for hypertension and COVID-19 treatment should immediately review their VAT treatment because RMC No. 56-2022 updates the List of VAT-Exempt Medicines under Republic […]